Novartis AG (NVSEF)
144.88
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Novartis EPS Diluted (Quarterly) : 1.647 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Addex Therapeutics Ltd. | -2.339 |
| Oculis Holding AG | -0.625 |
| Sanofi | -- |
| AstraZeneca PLC | 0.9849 |
| GSK Plc | 1.149 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.156B |
| Revenue (Quarterly) | 13.11B |
| Total Expenses (Quarterly) | 9.957B |
| Enterprise Value | 316.88B |
| Gross Profit Margin (Quarterly) | 73.78% |
| Profit Margin (Quarterly) | 24.07% |
| Earnings Yield | 4.82% |
| Operating Earnings Yield | 5.76% |
| Normalized Earnings Yield | 5.067 |